COH Cochlear Limited
Healthcare · Medical Devices
· website
· 5,500 employees
$120.74
52wk 88.74 – 315.22
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$7.90B
P/E (trailing)
22.87
P/E (forward)
23.29
EPS (trailing)
5.28
Dividend yield
3.6%
Payout ratio
81.5%
Beta
0.26
EV / EBITDA
14.06
Price / Book
4.08
ROE
18.1%
Operating margin
21.6%
Net margin
14.8%
Total cash
$187.10M
Total debt
$242.20M
Current ratio
2.46
Debt / Equity
0.12
Free cash flow
$104.08M
Avg volume
529,331
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$2.34B
- Gross profit$1.73B
- Operating income$406.10M
- Net income$388.90M
- Diluted EPS5.94
- Free cash flow$135.00M
- Net debt-$40.00M